Ekso Bionics Holdings, Inc. (EKSO)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
26. 43
+0.72
+2.8005%
$
38.57M Market Cap
- P/E Ratio
- Div Yield
365,731 Volume
-1.29 Eps
$ 25.71
Previous Close 
Want to track EKSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ekso Bionics Holdings, Inc. (EKSO) Statistics
Valuation metrics
Market Cap 38.57M
Enterprise value 38.9M
Trailing P/E (ttm) -2.95
Forward P/E -62.11
PEG ratio -0.1
Price/Sales (ttm) 3.34
Price/Book (mrq) 9.87
Enterprise Value/Revenue 3.36
Enterprise Value/EBITDA -2.91
Overview
Shares outstanding 3.56M
Float 2.24M
Shares short 215.1K
% Held by insiders 0.25%
% Held by institutions 0.27%
Average volume (10 days) 389.07K
Average volume (90 days) 172.57K
Price summary
52-Week low 2.91
52-Week high 30
Beta 0.78
50-Day moving average 21.01
200-Day moving average 11.32
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 2 Jun 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.36%
Operating margin -1.34%
Operational effectiveness
Return on assets -0.8%
Return on equity -1.77%
Income Statement
Revenue (ttm) 12.8M
Revenue per share (ttm) 3.25
Quarterly revenue growth (yoy) -0.38%
Gross profit (ttm) 6.84M
EBITDA -11M
Net income to common (ttm) -11.92M
Diluted EPS (ttm) -4.4
Quarterly earnings growth (yoy) -0.37%
Balance Sheet
Total cash (mrq) 1.17M
Total cash per share (mrq) 1.12
Total debt (mrq) 4.64M
Total Debt/Equity (mrq) 0.75
Current ratio (mrq) 1.55%
Book value per share (mrq) 1.61
Cash Flow
Cash flow statement -11.8M
Levered free cash flow (LFCF) -4.5M
